Luchman et al. obtained a tumor resection from a patient with grade 3 IDH-mutant astrocytoma and established a permanent cell line that preserved the IDH1 mutation and demonstrated self-renewal and multipotent capabilities [97]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).